Isis Pharmaceuticals To Present At Two Upcoming Investor Conferences
12:03 EDT 5 Sep 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
CARLSBAD, Calif., Sept. 5, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the following investor conferences:
Rodman & Renshaw A...
Other Sources for this Article
More From BioPortfolio on "Isis Pharmaceuticals To Present At Two Upcoming Investor Conferences"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
